NeoPharm CO., LTD. (KOSDAQ:092730)
South Korea
· Delayed Price · Currency is KRW 22,150
+950 (4.48%)
Apr 29, 2026, 3:30 PM KST
NeoPharm CO., LTD. Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 331,595 | 287,330 | 180,766 | 202,163 | 150,156 | 193,952 | Upgrade
|
| Market Cap Growth | 54.41% | 58.95% | -10.58% | 34.63% | -22.58% | -13.13% | Upgrade
|
| Enterprise Value | 191,771 | 154,628 | 66,098 | 78,166 | 45,545 | 97,728 | Upgrade
|
| Last Close Price | 21200.00 | 18370.00 | 11384.69 | 11811.25 | 8517.25 | 10615.43 | Upgrade
|
| PE Ratio | 11.92 | 10.33 | 7.84 | 8.71 | 8.82 | 10.95 | Upgrade
|
| Forward PE | 10.36 | 8.05 | 8.05 | 8.05 | 8.05 | 10.43 | Upgrade
|
| PS Ratio | 2.51 | 2.17 | 1.52 | 2.08 | 1.77 | 2.21 | Upgrade
|
| PB Ratio | 1.70 | 1.47 | 1.02 | 1.26 | 1.06 | 1.49 | Upgrade
|
| P/TBV Ratio | 1.71 | 1.48 | 1.03 | 1.28 | 1.07 | 1.51 | Upgrade
|
| P/FCF Ratio | 12.18 | 10.55 | 11.42 | 59.27 | 8.48 | 9.08 | Upgrade
|
| P/OCF Ratio | 11.67 | 10.11 | 9.70 | 8.69 | 8.27 | 8.95 | Upgrade
|
| PEG Ratio | - | 5.64 | 5.64 | 5.64 | 5.64 | 5.64 | Upgrade
|
| EV/Sales Ratio | 1.45 | 1.17 | 0.56 | 0.81 | 0.54 | 1.11 | Upgrade
|
| EV/EBITDA Ratio | 6.01 | 4.84 | 2.38 | 2.90 | 1.98 | 4.08 | Upgrade
|
| EV/EBIT Ratio | 6.66 | 5.37 | 2.68 | 3.09 | 2.12 | 4.36 | Upgrade
|
| EV/FCF Ratio | 7.04 | 5.68 | 4.18 | 22.92 | 2.57 | 4.58 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | 0.06 | 0.06 | 0.02 | 0.04 | 0.02 | 0.02 | Upgrade
|
| Debt / FCF Ratio | 0.07 | 0.07 | 0.04 | 0.31 | 0.02 | 0.03 | Upgrade
|
| Net Debt / Equity Ratio | -0.72 | -0.72 | -0.71 | -0.69 | -0.79 | -0.80 | Upgrade
|
| Net Debt / EBITDA Ratio | -4.38 | -4.38 | -4.53 | -4.11 | -4.90 | -4.37 | Upgrade
|
| Net Debt / FCF Ratio | -5.14 | -5.14 | -7.95 | -32.52 | -6.39 | -4.89 | Upgrade
|
| Asset Turnover | 0.64 | 0.64 | 0.64 | 0.58 | 0.57 | 0.64 | Upgrade
|
| Inventory Turnover | 3.24 | 3.24 | 3.93 | 3.35 | 3.19 | 3.18 | Upgrade
|
| Quick Ratio | 7.32 | 7.32 | 9.21 | 7.22 | 9.22 | 8.74 | Upgrade
|
| Current Ratio | 8.40 | 8.40 | 10.12 | 7.94 | 9.99 | 9.39 | Upgrade
|
| Return on Equity (ROE) | 14.95% | 14.95% | 13.69% | 15.36% | 12.50% | 14.28% | Upgrade
|
| Return on Assets (ROA) | 8.77% | 8.77% | 8.33% | 9.50% | 8.97% | 10.14% | Upgrade
|
| Return on Invested Capital (ROIC) | 44.62% | 46.59% | 37.61% | 51.12% | 56.96% | 64.53% | Upgrade
|
| Return on Capital Employed (ROCE) | 14.60% | 14.60% | 13.90% | 15.80% | 15.10% | 17.20% | Upgrade
|
| Earnings Yield | 8.39% | 9.68% | 12.76% | 11.48% | 11.34% | 9.13% | Upgrade
|
| FCF Yield | 8.21% | 9.47% | 8.76% | 1.69% | 11.79% | 11.01% | Upgrade
|
| Dividend Yield | 3.73% | 4.08% | 5.27% | 3.17% | 4.11% | 3.30% | Upgrade
|
| Payout Ratio | 33.73% | 33.73% | 25.43% | 23.58% | 32.15% | 28.70% | Upgrade
|
| Buyback Yield / Dilution | - | - | - | - | - | 0.95% | Upgrade
|
| Total Shareholder Return | 3.73% | 4.08% | 5.27% | 3.17% | 4.11% | 4.24% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.